🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical trial is to learn about the safety and how wel...
Status
Completed
Location
Nirmal Hospital Pvt Ltd.
Start Date
2022-07-16
Trial ID
NCT05375929
Treatments Being Tested
B7451012 is a Phase 3 study to evaluate PF-04965842 in patients aged 12 yea...
Status
Completed
Location
Clinical Research Center of Alabama, LLC
Start Date
2017-12-07
Trial ID
NCT03349060
Treatments Being Tested
B7451029 is a Phase 3 study to investigate PF-04965842 in adult patients wh...
Status
Completed
Location
Clinical Research Center of Alabama, LLC
Start Date
2018-10-29
Trial ID
NCT03720470
Treatments Being Tested
This study aims to evaluate the safety, efficacy and tolerability of abroci...
Status
Completed
Location
INNO-6052 Site 12
Start Date
2024-05-31
Trial ID
NCT06283550
Treatments Being Tested
B7451037 is a randomized, double-blind, placebo-controlled, parallel-group,...
Status
Completed
Location
California Dermatology & Clinical Research Institute
Start Date
2020-06-18
Trial ID
NCT03915496
Treatments Being Tested
B7451014 is a Phase 3 study to investigate PF-04965842 in patients aged 12 ...
Status
Completed
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2018-06-11
Trial ID
NCT03627767
Treatments Being Tested
This is a Phase 1, randomized, 2 way crossover, open-label study of the eff...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2018-09-26
Trial ID
NCT03662516
Treatments Being Tested
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical...
Status
Completed
Location
Total Skin and Beauty Dermatology Center, PC
Start Date
2018-03-08
Trial ID
NCT03422822
B7451013 is a Phase 3 study to evaluate PF-04965842 in patients aged 12 yea...
Status
Completed
Location
Emmaus Research Center, Inc.
Start Date
2018-06-29
Trial ID
NCT03575871
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics, safety and tol...
Status
Completed
Location
Beijing Hospital Sub-Center of Beijing Hospital Clinical Trial & Research Center
Start Date
2019-10-14
Trial ID
NCT04099563
Treatments Being Tested